Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed FCF Margin for 7 consecutive years, with 54.51% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 4784.0% to 54.51% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 15.81% through Dec 2025, up 1339.0% year-over-year, with the annual reading at 12.75% for FY2025, 1033.0% up from the prior year.
  • FCF Margin hit 54.51% in Q4 2025 for Eton Pharmaceuticals, down from 52.28% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 117.02% in Q1 2025 to a low of 380.9% in Q3 2021.
  • Historically, FCF Margin has averaged 7.79% across 5 years, with a median of 13.13% in 2024.
  • Biggest YoY gain for FCF Margin was 1425297bps in 2021; the steepest drop was -24095071bps in 2021.
  • Year by year, FCF Margin stood at 84.05% in 2021, then surged by 140bps to 33.28% in 2022, then crashed by -96bps to 1.3% in 2023, then tumbled by -614bps to 6.67% in 2024, then plummeted by -717bps to 54.51% in 2025.
  • Business Quant data shows FCF Margin for ETON at 54.51% in Q4 2025, 52.28% in Q3 2025, and 42.05% in Q2 2025.